BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28621822)

  • 1. cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.
    Takahashi H; Tsuboi H; Asashima H; Hirota T; Kondo Y; Moriyama M; Matsumoto I; Nakamura S; Sumida T
    Clin Exp Immunol; 2017 Oct; 190(1):96-109. PubMed ID: 28621822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjögren's syndrome.
    Vartoukian SR; Tilakaratne WM; Seoudi N; Bombardieri M; Bergmeier L; Tappuni AR; Fortune F
    Clin Exp Immunol; 2014 Sep; 177(3):618-29. PubMed ID: 24827536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell-adhesion molecules in the salivary gland microenvironment of Sjögren's syndrome.
    St Clair EW; Angellilo JC; Singer KH
    Arthritis Rheum; 1992 Jan; 35(1):62-6. PubMed ID: 1370620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T cell-secreted IFN-γ in Sjögren's syndrome induces salivary gland epithelial cell ferroptosis.
    Zhou J; Pathak JL; Cao T; Chen B; Wei W; Hu S; Mao T; Wu X; Watanabe N; Li X; Li J
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167121. PubMed ID: 38471652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique glandular ex-vivo Th1 and Th17 receptor motifs in Sjögren's syndrome patients using single-cell analysis.
    Voigt A; Bohn K; Sukumaran S; Stewart CM; Bhattacharya I; Nguyen CQ
    Clin Immunol; 2018 Jul; 192():58-67. PubMed ID: 29679709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of circulating SLAMF7
    Higashioka K; Ota Y; Maehara T; Moriyama M; Ayano M; Mitoma H; Akahoshi M; Arinobu Y; Horiuchi T; Nakamura S; Akashi K; Niiro H
    BMC Immunol; 2020 Jun; 21(1):31. PubMed ID: 32487061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomics unveil profiles and interplay of immune subsets in rare autoimmune childhood Sjögren's disease.
    Kim MC; De U; Borcherding N; Wang L; Paek J; Bhattacharyya I; Yu Q; Kolb R; Drashansky T; Thatayatikom A; Zhang W; Cha S
    Commun Biol; 2024 Apr; 7(1):481. PubMed ID: 38641668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome.
    Xiao F; Lin X; Tian J; Wang X; Chen Q; Rui K; Ma J; Wang S; Wang Q; Wang X; Liu D; Sun L; Lu L
    Cell Mol Immunol; 2017 Jul; 14(11):924-34. PubMed ID: 28690324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraction of characteristic serum microRNAs and prediction of target genes in IgG4-related dacryoadenitis and sialadenitis.
    Yamamoto M; Tanaka T; Aochi S; Uehara M; Kamekura R; Takano KI
    Mod Rheumatol; 2024 Mar; 34(3):632-638. PubMed ID: 37747366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
    Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
    Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal distribution of AQP4 in minor salivary glands of primary Sjögren's syndrome patients.
    Sisto M; Lorusso L; Ingravallo G; Nico B; Ribatti D; Ruggieri S; Lofrumento DD; Lisi S
    Autoimmunity; 2017 Jun; 50(4):202-210. PubMed ID: 28648105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Helper 17 Cells in Primary Sjögren's Syndrome.
    Matsui K; Sano H
    J Clin Med; 2017 Jul; 6(7):. PubMed ID: 28678161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral disorders, saliva secretion, and oral health-related quality of life in patients with primary Sjögren's syndrome.
    Rusthen S; Young A; Herlofson BB; Aqrawi LA; Rykke M; Hove LH; Palm Ø; Jensen JL; Singh PB
    Eur J Oral Sci; 2017 Aug; 125(4):265-271. PubMed ID: 28643390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.
    Li H; Reksten TR; Ice JA; Kelly JA; Adrianto I; Rasmussen A; Wang S; He B; Grundahl KM; Glenn SB; Miceli-Richard C; Bowman S; Lester S; Eriksson P; Eloranta ML; Brun JG; Gøransson LG; Harboe E; Guthridge JM; Kaufman KM; Kvarnström M; Cunninghame Graham DS; Patel K; Adler AJ; Farris AD; Brennan MT; Chodosh J; Gopalakrishnan R; Weisman MH; Venuturupalli S; Wallace DJ; Hefner KS; Houston GD; Huang AJW; Hughes PJ; Lewis DM; Radfar L; Vista ES; Edgar CE; Rohrer MD; Stone DU; Vyse TJ; Harley JB; Gaffney PM; James JA; Turner S; Alevizos I; Anaya JM; Rhodus NL; Segal BM; Montgomery CG; Scofield RH; Kovats S; Mariette X; Rönnblom L; Witte T; Rischmueller M; Wahren-Herlenius M; Omdal R; Jonsson R; Ng WF; ; Nordmark G; Lessard CJ; Sivils KL
    PLoS Genet; 2017 Jun; 13(6):e1006820. PubMed ID: 28640813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune Complexes.
    Burbelo PD; Gunti S; Keller JM; Morse CG; Deeks SG; Lionakis MS; Kapoor A; Li Q; Cohen JI; Notkins AL; Alevizos I
    Sci Rep; 2017 Jun; 7(1):3818. PubMed ID: 28630417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.
    Ebina K; Hirao M; Hashimoto J; Hagihara K; Kashii M; Kitaguchi K; Matsuoka H; Iwahashi T; Chijimatsu R; Yoshikawa H
    J Bone Miner Metab; 2018 Jul; 36(4):478-487. PubMed ID: 28766140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance imaging of parotid glands before and after abatacept therapy in patients with Sjögren's syndrome associated with rheumatoid arthritis: Utility to evaluate and predict response to treatment.
    Takahashi H; Tsuboi H; Yokosawa M; Asashima H; Hirota T; Kondo Y; Matsumoto I; Sumida T
    Mod Rheumatol; 2018 Mar; 28(2):300-307. PubMed ID: 28722506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and Safety of CRAC Inhibitors in Human Rheumatoid Arthritis Xenograft Models.
    Liu S; Hasegawa H; Takemasa E; Suzuki Y; Oka K; Kiyoi T; Takeda H; Ogasawara T; Sawasaki T; Yasukawa M; Maeyama K
    J Immunol; 2017 Sep; 199(5):1584-1595. PubMed ID: 28716825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development.
    Haacke EA; van der Vegt B; Vissink A; Spijkervet FKL; Bootsma H; Kroese FGM
    Ann Rheum Dis; 2017 Oct; 76(10):1781-1784. PubMed ID: 28710097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.
    Wu MC; Xu X; Chen SM; Tyan YS; Chiou JY; Wang YH; Lin LC; Chen CM; Wei JC
    PLoS One; 2017; 12(7):e0175836. PubMed ID: 28704397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.